Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Eur J Cancer. 2010 May 23;46(11):2097–2103. doi: 10.1016/j.ejca.2010.04.022

Fig 3.

Fig 3

Correlation of UGT1A1*28 genotype with SN-38 glucuronide formation rates in the presence of 0 (A), 0.15 (B), 0.5 (C), or 2 μM erlotinib (D) on SN-38 glucuronidation in 9 Caucasian liver microsomes. Incubations were performed as described under Materials and Methods. Data represent means of duplicate determinations.